First-year discontinuation commonly reflects high out-of-pocket costs coupled with expectations that weight loss will be ...

In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug ...

In today's Pharmaceutical Executive Daily, President Trump signs an executive order imposing 100% tariffs on imported ...

The U.S. pharmaceutical market is at a critical inflection point in early 2026. For decades, the industry has operated within a framework that, while fostering significant innovation, has also ...

The Trump administration has also pushed back against Covid vaccine recommendations, and the FDA toughened its requirements ...

Khedkar was elected CEO of ZS in July 2021. Prior to assuming the role, he led the firm’s global pharmaceuticals practice for ...

Earlier this year, PacBio announced a collaboration with global rare disease genomics program iHope (part of the Genetic ...

When the bubble bursts, the tools that survive will not be the ones that generated the best demos. They will be the ones ...

Imunon’s CEO discusses how FDA allowing the Bayesian method impacts innovation in the clinical trial space. Members of PacBio and iHope discuss collaboration and the global state of genomic testing.

Most importantly, pharmaceutical companies that negotiated agreements with the Trump administration for its Most Favored ...